pillbase.ru

Lorviqua

Active substance: lorlatinib

Lorlatinib

Centralised EU authorisationActive

Marketing holder: Pfizer Europe MA EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • Lorbrena
    TABLET, FILM COATED · LORLATINIB 25 mg/1
    63539-927
    U.S. Pharmaceuticals
  • Lorbrena
    TABLET, FILM COATED · LORLATINIB 100 mg/1
    0069-0231
    Pfizer Laboratories Div Pfizer Inc
  • Lorbrena
    TABLET, FILM COATED · LORLATINIB 25 mg/1
    0069-0227
    Pfizer Laboratories Div Pfizer Inc
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12092-3262-7bfc-b63d-afd286becfb5,01a12095-365e-7591-b282-d5d81cf72b0e,01a1209a-37a6-70bc-8d8d-a182f01e1fa0;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004646
Registration status
Active
ATC code
L01ED05
Sources
  • product · EMA · EMEA/H/C/004646 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004646 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004646 · Verified 2026-10-09